Layer-3 dosing schedule for use in the treatment of cancer

• 收藏
• 分享

专利权人:

Immutep

发明人:

TRIEBEL, Frédéric

申请号：

DK12196316

公开号：

DK2601962T3

申请日:

2008.10.03

申请国别(地区):

DK

年份:

2019

代理人:

摘要：

The present invention relates to the use of a recombinant LAG-3 or derivatives thereof in order to boost a monocyte-mediated immune response, in particular to elicit an increase in the number of monocytes in blood. This finds use in the development of novel therapeutic agents for the treatment of an infectious disease or cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/